Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells

Journal of Cell Biology

Volumn 145, Issue 4, 1999, Pages 727-740

  Hayashi, Ken'ichiro ^a   Takahashi, Masanori ^a   Kimura, Kazuhiro ^a   Nishida, Wataru ^a   Saga, Hiroshi ^a   Sobue, Kenji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

ERK; Mitogen activated protein kinases; P38MAPK; Phosphoinositide 3 kinase; Smooth muscle cells

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHICKEN; ENZYME ACTIVITY; INTESTINE MUSCLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL LINE; CHICK EMBRYO; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GIZZARD; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE KINASE 1; MAP KINASE KINASE 6; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSFECTION; VISCERA;

ANIMALIA; GALLUS GALLUS;

EID: 0033577854     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.145.4.727     Document Type: Article

References (51)

1. Alessi, D.R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8:55-62.
2. Berrou, E., M. Fontenay-Roupie, R. Ouarck, F.R. McKenzie, S. Levy-Toledano, G. Tobelem, and M. Bryckaert. 1996. Transforming growth factor β1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells. Biochem. J. 316:167-173.
3. Bornfeldt, K.E., H.L. Arnqvist, and G. Norstedt. 1990. Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells. J. Endocrinol. 125:381-386.
4. Bornfeldt, K.E., E.W. Rainco, T. Nateano, L.M. Groves, E. Krebs, and R. Ross. 1994. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93: 1266-1274.
5. Cercek, B., M.C. Fishbein, J.S. Forrester, R.H. Helfant, and J.A. Fagin. 1990. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ. Res. 66:1755-1760.
6. Chamley-Campbell, J., G.R. Campbell, and R. Ross. 1979. The smooth muscle cell in culture. Physiol. Rev. 59:1-61.
7. Gemmons, D.R. 1985. Variables controlling the secretion of a somatomedin-like peptide by cultured porcine smooth muscle cells. Circ. Res. 56:418-426.
8. Cohen, P. 1997. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell biol. 7:353-361.
9. Dario, R.A., A. Mirjana, C. Barry, P. Cron, M. Nick, P. Cohen, and B.A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-I. EMBO (Eur. Mol. Biol. Organ.) J. 23:6541-6551.
10. Davis, R.J. 1994. MAPKs: new JNK expands the group. Trends Biochem. Sci. 19:470-473.
11. Delafontaine, P., H. Lou, and R.W. Alexander. 1991. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension. 18:724-747.
12. Denharrdt, D.T. 1996. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell. Biochem. J. 318:729-747.
13. Derijard, B., M. Hibi, I.H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R.J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1025-1037.
14. Force, T., and J.V. Bonventre. 1998. Growth factors and mitogen-activated protein kinases. Hypertension. 31:152-161.
15. Gimona, M., Furst, D.O., and J.V. Small. 1987. Metavinculin and vinculin from mammalian smooth muscle: bulk isolation and characterization. J. Muscle Res. Cell Motil. 8:329-341.
16. Gimona, M., M.P. Sparrow, P. Strasser, M. Herzog, and J.V. Small. 1992. Calponin and SM 22 isoforms in avian and mammalian smooth muscle. Absence of phosphorylation in vivo. Eur J Biochem. 205:1067-1075.
17. Glukhova, M., V. Koteliansky, C. Fondacci, F. Marotte, and L. Rappaport. 1993. Laminin variants and integrin laminin receptors in developing and adult human smooth muscle. Dev. Biol. 157:437-447.
18. Hayashi, K., Y. Fujio, I. Kalo, and K. Sobue. 1991. Structural and functional relationships between h- and l-caldesmons. J. Biol. Chem. 266:355-361.
19. Hayashi, K., H. Yano, T. Hashida, R. Takeuchi, O. Tukeda, K. Asada, E. Takahashi, I. Kato, and K. Sohue. 1992. Genomic structure of the human caldesmon gene. Proc. Nail. Acad. Sci. USA. 89:12122-12126.
20. Hayashi, K., H. Saga, Y. Chimori, K. Kimura, Y. Yamanaka, and K. Sobue. 1998. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J. Biol. Chem. 273:28860-28867.
21. Hu, Q., A. Klippel, A.J. Muslin, W.J. Fantl, and L.T. Williams. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 268:100-102.
22. Hu, Y., L. Cheng, B.W. Hochleitner, and Q. Xu. 1997. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol 17: 2808-2816.
23. Jones, P.L., K.N. Cowan, and M. Rabinnovitch. 1997. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am. J. Pathol. 150:1349-1360.
24. Kashiwada, K., W. Nishida, K. Hayashi, K. Ozawa, Y. Yamanaka, H. Saga, T. Yamashita, M. Tohyama, S. Shimada, K. Sato, and K. Sohue. 1997. Coordinate expression of α-tropomyosin and caldesmon isoforms in association with phenotypic modulation of smooth muscle cells. J. Biol. Chem. 272: 15396-15404.
25. Katoh, Y., E. Loukianov, E. Kopras, A. Zilberman, and M. Periasamy. 1994. Identification of functional promoter elements in the rabbit smooth muscle myosin heavy chain gene. J. Biol. Chem. 269:30538-30545.
26. Kim, S., H.S. Ip, M.M. Lu, C. Clendenin, and M.S. Parmacek. 1997. A serum response factor dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol. Cell. Biol. 17:2266-2278.
27. Kuro-o, M., R. Nagai, H. Tsuchimochi, H. Katoh, Y. Yazaki, A. Ohkubo, and F. Takaku. 1989. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J. Biol. Chem. 264:18272-18275.
28. Kyrian, J.M., and J. Avruch. 1996. Sounding the alarm: protein kinase cascades activated by stress inflammation. J. Biol. Chem. 271:24313-24316.
29. Larrivee, J.F., D.R. Bachvarov, F. Houle, J. Landry, J. Huot, and F. Marceau. 1998. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J. Immunol. 160:1419-1426.
30. Madsen, C.S., J.C. Hershey, M.B. Hautmann, S.L. White, and O.K. Owens. 1997. Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J. Biol. Chem. 272:6332-6340.
31. Mansour, S.J., W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Vande Woude, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265: 966-970.
32. Miyamoto, T., I. Leconte, J.L. Swain, and J.C. Fox. 1998. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro. J Cell Phyiol. 117:58-67.
33. Nagai, R., M. Kuro-o, P. Babij, and M. Periasamy. 1989. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J. Biol. Chem. 264:9734-9737.
34. Obata, H., K. Hayashi, W. Nishida, T. Momiyama, and K. Sobue. 1997. Smooth muscle cell phenotype-dependent transcriptional regulation of the α1 integrin gene. J. Biol. Chem. 272:26648-26651.
35. Owens, G.K. 1995, Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
36. Pyles, J.M., K.L. March, M. Franklin, K. Mehdi, R.K. Wilensky, and L.P. Adam. 1997. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ. Res. 81:904-910.
37. Pyne, N.J., and S. Pyne. 1997. Platelet-derived growth factor activates a mammalian Ste20 coupled mitogen-activated protein kinase in airway smooth muscle. Cell. Signal. 9:311-317.
38. Raingeaud, J., A.J. Whitmarsh, T. Barrett, B. Derijard, and R.J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p.38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16: 1247-1255.
39. Ray, L.B., and T.W. Rturgill. 1988. Insulin-stimulated microtuble-associated protein kinase is phosphorylated on tyrosine and threonin in vivo, Proc. Natl. Acad. Sci. USA. 85:3753-3757.
40. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature: 362:801-809.
41. Shanahan, C.M., P.L. Weissberg, and J.C. Necalfe. 1993. Isolation of gene-markers of differentiated and proliferating vascular smooth muscle cells. Cir. Res. 73:193-204.
42. 2-terminal kinase groups of mitogen activated protein kinases. J. Biol. Chem. 271:5750-5754.
43. Sjolund, M., U. Hedin, T. Sejersen, C.H. Heldin, and J. Tyberg. 1988. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen. and bind exogenous PDGF in a phenotype- and growth state-dependent manner. J. Cell. Biol. 106:403-413.
44. Sobue, K., and J.R. Sellers. 1991. Caldesmon a novel regulatory protein in smooth muscle and nonmuscle actomyosin system. J. Biol. Chem. 266:12115-12118.
45. Sobue, K., K. Kanda, T. Tanaka, and N. Ueki. 1988. Caldesmon: a common actin-ligand regulatory protein in the smooth muscle and non-muscle contractile system. J. Cell. Biochem. 37:317-325.
46. Sobue, K., K. Hayashi, and W. Nishida. 1998. Molecular mechanism of phenotypic modulation of smooth muscle cells. Horm. Res. 50:15-24.
47. Solway, J., J. Seltzer, F.F. Samaha, S. Kim, L.E. Alger, O. Niu, E.E. Morrisey, and M.S. Parmacek. 1995. Structure and expression of a smooth muscle cell-specific gene. SM22α. J. Biol. Chem. 270:13460-13469.
48. Ueki, N., K. Sobue, K. Kanda, T. Hada, and K. Higashino. 1987. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc. Natl. Acad. Sci. USA. 84:9049-9053.
49. Yano, H., K. Hayashi, T. Momiyama, H. Saga, M. Haruna, and K. Sobue. 1995. Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J. Biol. Chem. 270:23661-23666.
50. Yu, S.M., L.M. Hung, and C.C. Lin. 1997. CGMP-clevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circ. 95:1269-1277.
51. Xu, Q., Y. Liu, M. Gorospe, R. Udelsman, and N.J. Holbrook. 1996. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J. Clin. Invest. 97:508-514.